HealthcareNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1655923ACOG stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $10.2M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ACOG Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Alpha Cognition Inc. (ACOG), a Healthcare sector company. ACOG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $10.2m in revenue. Based on the latest XBRL financial filings (Q1 2026), Alpha Cognition Inc. reports quarterly revenue of $3.5M, net income of $-6.5M, free cash flow of $-11.8M. Top institutional holders of ACOG by reported 13-F value include Opaleye Management, Solas Capital Management,, AWM Investment Company,, based on the most recent SEC filings. ACOG trades on the Nasdaq exchange and files with the SEC under CIK 1655923. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACOG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alpha Cognition Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$3.5M

Net Income

Q1 2026

$-6.5M

Free Cash Flow

Q1 2026

$-11.8M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

$10.2MFY 2025
FY22 FY23 FY24 FY25 $10.2M

Net Income

-39.8% YoY
$-20.7MFY 2025
FY22 FY23 $-13.8MFY24 $-14.8MFY25 $-20.7M

Operating Income

-88.6% YoY
$-22.7MFY 2025
FY22 FY23 $-9.9MFY24 $-12.0MFY25 $-22.7M

EPS (Diluted)

+42.2% YoY
$-1.18FY 2025
FY22 FY23 $-3.84FY24 $-2.04FY25 $-1.18

Total Assets

+57.1% YoY
$79.7MFY 2025
FY22 FY23 $2.5MFY24 $50.7MFY25 $79.7M

Op. Cash Flow

-162.8% YoY
$-20.4MFY 2025
FY22 FY23 $-8.8MFY24 $-7.8MFY25 $-20.4M

AI Insight: ACOG Financial Trends

Alpha Cognition is burning cash with accelerating operating losses despite modest revenue growth, signaling a pre-inflection biotech in distress.

Revenue grew from $0M in Q3 2024 to $4M in Q1 2026, but operating losses widened from $-2M to $-8M.

Operating cash flow deteriorated to $-12M in Q1 2026, worst quarterly burn since tracking began.

Equity volatility: swung from $-3M (Q3 2024) to $63M (Q4 2025), then declined to $57M (Q1 2026).

Operating losses accelerating despite revenue growth—cash burn rate now $-12M/quarter. Runway at risk.

Net income swung from $-10M loss (Q2 2025) to $-1M (Q3 2025), then deteriorated again to $-7M, $-6M.

AI Insight: ACOG Ratio Trends

Alpha Cognition is deeply unprofitable across all return metrics, with ROIC worsening to -56.4% in Q1 2026 despite modest ROE improvement from Q2 2025 trough.

Operating margin deteriorated to -187.0% in Q3 2025, then improved to unmeasured in Q4 2025 and Q1 2026; NPM hit -183.3% in Q1 2026.

ROE improved from -131.5% in Q2 2025 to -45.1% in Q1 2026; ROA similarly recovered from -93.0% to -37.4% over same span.

ROIC declined from -36.1% in Q1 2025 to -56.4% in Q1 2026, the worst result in available data, signaling accelerating capital destruction.

Extreme negative margins (-187% OpMargin, -183% NPM) indicate severe cash burn and unsustainable operations; path to profitability unclear.

No debt/equity data available; inability to assess leverage or financing constraints during persistent losses.

Get alerted when ACOG's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Alpha Cognition Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of ACOG

Put ACOG on your watchlist

Track score changes the day Alpha Cognition Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ACOG a good stock to buy?

13F Pro's AI-powered analysis of Alpha Cognition Inc. (ACOG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACOG are available on the ACOG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ACOG?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACOG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alpha Cognition Inc.'s investment landscape.